Home
About
Management Team
Board of Directors
Investors
Therapeutic Areas
R&D Programs
Mechanism of Action
Product candidates
News
Contact
News
Innerva Pharmaceuticals closes 2.3 million Euro round led by Inveready
READ MORE
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
